EPRX
Eupraxia Pharmaceuticals
EPRX
EPRX
14 hedge funds and large institutions have $10.9M invested in Eupraxia Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$329K | |
| 2 | +$143K | |
| 3 | +$61.5K | |
| 4 |
CIBC World Market
Toronto,
Ontario, Canada
|
+$57.6K |
| 5 |
QC
Quadrature Capital
London,
United Kingdom
|
+$41.1K |
Top Sellers
| 1 | -$1M | |
| 2 | -$366K | |
| 3 | -$57.6K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$52.6K |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$131 |